๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of valproic acid in volunteers after a single dose study

โœ Scribed by Meir Bialer; Ziad Hussein; Itamar Raz; Oded Abramsky; Yuval Herishanu; Freddy Pachys


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
432 KB
Volume
6
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

โœฆ Synopsis


The pharmacokinetics of valproic acid (VPA) was investigated in six healthy volunteers. This was done by monitoring total and free (unbound) valproic acid levels in the serum, and the amount of one of its metabolites, VPA glucuronide, in the urine as a function of time, after a single dose administration of the parent drug. VPA half-life calculated from the urine data of the metabolite was shorter than the half-life calculated from the blood data. About 15 to 20 per cent of the administered oral dose of VPA was excreted in the urine as VPA glucuronide. The average free fraction of VPA obtained in this study, by using the EMIT technique, ranged from 1.5 to 11.5 per cent with a mean value of 4.9 per cent.


๐Ÿ“œ SIMILAR VOLUMES


Single dose pharmacokinetics and bioavai
โœ Michael J. Lamson; John P. Sabo; Thomas R. Macgregor; Joseph W. Pav; Lois Rowlan ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 170 KB ๐Ÿ‘ 2 views

The results of two randomized, single-dose, crossover bioavailability studies are presented which describe the pharmacokinetics and oral bioavailability of nevirapine, a novel nonnucleoside antiretroviral drug. In the first study 12 healthy male volunteers received nevirapine 15 mg via short-term i.

Single dose pharmacokinetics of HEPP, a
โœ Dinora F. Gonzรกlez-Esquivel; Francisco Rubio-Donnadieu; Guillermo Carvajal S.; H ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 128 KB ๐Ÿ‘ 2 views

The pharmacokinetics and the dose proportionality of a new anticonvulsant compound, HEPP (D,L-3-hydroxy-3-ethyl-3-phenylpropionamide) was studied in healthy male volunteers as part of the pharmacological evaluation for new drugs. Study was performed administering doses of 250, 375, 500 and 625 mg of

Repeated dose pharmacokinetics of pancop
โœ P. Salva; J. Costa; A. Perez-Campos; Dr A. Martinez-Tobed ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 421 KB ๐Ÿ‘ 1 views

The aim of this study was to assess the pharmacokinetic profile of pancopride after repeated oral dose administration of 20mg pancopride in tablet form once a day for 5 d in 12 healthy male volunteers. Plasma levels were measured by HPLC using a solid phase extraction method and automated injection.

The single dose pharmacokinetics and saf
โœ Harri Kanerva; Olavi Kilkku; Esa Heinonen; Antti Helminen; Juha Rouru; Simo Tarp ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 201 KB ๐Ÿ‘ 2 views

The pharmacokinetics and tolerability of a new putative non-benzodiazepine type anxiolytic compound deramciclane was studied in two consecutive studies. An open dose-escalation design was used to study doses from 0.2 to 50 mg in 18 healthy male volunteers. In the second study doses from 50 to 150 mg

A dose-dependent pharmacokinetic study o
โœ Yow-Shieng Uang; Kuang-Yang Hsu ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 249 KB ๐Ÿ‘ 2 views

The dose-dependent pharmacokinetics of caeic acid (CA) were studied in rabbits. Three dierent doses (5, 10, and 25 mg kg 71 ) were administered intravenously to six rabbits each. The concentrationยฑtime proยฎles for CA could be ยฎtted by a twocompartment model for each dose. The results showed that tot